Influence of tumour history in valve damage in patients undergoing mitral or aortic valve replacement

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Maite Odriozola Garmendia

Navarra University Hospital, Pamplona, Navarra (Spain)

8 More presentations in this session

Presentation thumbnail

Discussant - Biomarkers, biomechanics, and innovations in valve and vascular disorders

Presentation thumbnail

Benefits of extubation after the Fontan operation: a theoretical analysis using serial patient-specific Fontan computational fluid dynamics models

Doctor K. Sughimoto (Chiba, JP)

Presentation thumbnail

Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis

Doctor Y. Morimoto (Suita, JP)

Presentation thumbnail

Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk

Ms K. Lee (Singapore, SG)

Presentation thumbnail

Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis

Doctor M. Al Zaidi (Bonn, DE)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Clinical outcomes of TAVI in patients with active cancer: a bridge to success?

Congress Presentation

Valvular heart disease in Cancer patiEntS - prevAlence, Relevance, and therapeutic management - preliminary results from the CESAR study

Congress Presentation

Sex-dependent effects of anthracyclines on valvular cells calcification

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources